Corvus Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 05/15/2026 | 7.17 M | $104.82 M | 0.00% | 9.07% |
| BLACKROCK, INC. | 05/13/2026 | 6.16 M | $90.13 M | 21.84% | 7.80% |
| STATE STREET CORP | 05/15/2026 | 3.57 M | $52.17 M | 27.89% | 4.52% |
| ADAMS STREET PARTNERS LLC | 05/15/2026 | 3.28 M | $47.92 M | 0.00% | 4.15% |
| 05/15/2026 | 3.23 M | $47.32 M | 100.00% | 4.10% | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 2.92 M | $42.68 M | 8,453.88% | 3.69% |
| VIVO CAPITAL, LLC | 05/20/2026 | 2.81 M | $41.05 M | 25.56% | 3.55% |
| MORGAN STANLEY | 05/15/2026 | 2.50 M | $36.56 M | -29.96% | 3.16% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 2.49 M | $36.45 M | 100.00% | 3.16% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 2.32 M | $33.92 M | 636.78% | 2.94% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 2.29 M | $33.54 M | 231.07% | 2.90% |
| COMMODORE CAPITAL LP | 05/15/2026 | 2.26 M | $33.05 M | 100.00% | 2.86% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 05/15/2026 | 1.83 M | $26.79 M | 32.58% | 2.32% |
| BRAIDWELL LP | 05/15/2026 | 1.75 M | $25.64 M | 100.00% | 2.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.71 M | $25.06 M | 16.27% | 2.17% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.67 M | $24.50 M | -38.96% | 2.12% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.54 M | $22.54 M | 178.46% | 1.95% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.34 M | $19.53 M | 100.00% | 1.69% |
| BOXER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.10 M | $16.09 M | 100.00% | 1.39% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 1.07 M | $15.66 M | 100.00% | 1.36% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2026 | 891.93 K | $13.05 M | 100.00% | 1.13% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 866.36 K | $12.67 M | 25.78% | 1.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 750.00 K | $10.97 M | 100.00% | 0.95% |
| EMERALD ADVISERS, LLC | 05/04/2026 | 686.22 K | $10.04 M | 100.00% | 0.87% |
| 05/08/2026 | 669.90 K | $9.80 M | 100.00% | 0.85% | |
| DCF ADVISERS, LLC | 05/11/2026 | 637.50 K | $9.33 M | -12.55% | 0.81% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 550.00 K | $8.05 M | 100.00% | 0.70% |
| MARSHALL WACE, LLP | 05/15/2026 | 548.29 K | $8.02 M | 153.54% | 0.69% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/14/2026 | 545.00 K | $7.97 M | 100.00% | 0.69% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 543.40 K | $7.95 M | 57.92% | 0.69% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 539.87 K | $7.90 M | 275.96% | 0.68% |
| NORTHERN TRUST CORP | 05/14/2026 | 506.10 K | $7.40 M | 17.76% | 0.64% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 504.63 K | $7.38 M | 100.00% | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 05/04/2026 | 459.25 K | $6.72 M | 100.00% | 0.58% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 450.00 K | $6.58 M | 100.00% | 0.57% |
| NEXTECH INVEST, LTD. | 05/15/2026 | 450.00 K | $6.58 M | 100.00% | 0.57% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 450.00 K | $6.58 M | -10.00% | 0.57% |
| CITADEL ADVISORS LLC | 05/15/2026 | 442.52 K | $6.47 M | 112.57% | 0.56% |
| UBS GROUP AG | 05/05/2026 | 289.11 K | $4.23 M | 36.37% | 0.37% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 278.01 K | $4.07 M | 100.00% | 0.35% |
| CITADEL ADVISORS LLC | 05/15/2026 | 267.80 K | $3.92 M | 185.50% | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 247.96 K | $3.63 M | -39.18% | 0.31% |
| DIADEMA PARTNERS LP | 05/15/2026 | 244.81 K | $3.58 M | 100.00% | 0.31% |
| BARCLAYS PLC | 05/15/2026 | 243.78 K | $3.57 M | -38.25% | 0.31% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 237.00 K | $3.47 M | 0.22% | 0.30% |
| 05/14/2026 | 231.59 K | $3.39 M | 100.00% | 0.29% | |
| 05/07/2026 | 226.84 K | $3.32 M | 100.00% | 0.29% | |
| JANE STREET GROUP, LLC | 05/12/2026 | 217.80 K | $3.19 M | 462.79% | 0.28% |
| CITADEL ADVISORS LLC | 05/15/2026 | 202.40 K | $2.96 M | 15.66% | 0.26% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 188.13 K | $2.75 M | 9.91% | 0.24% |
Corvus Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 208 institutional investors and hedge funds held shares of Corvus Pharmaceuticals Inc. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 7.17 M
BlackRock, Inc.: 6.16 M
STATE STREET CORP: 3.57 M
ADAMS STREET PARTNERS LLC: 3.28 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.92 M
Vivo Capital, LLC: 2.81 M
88.61% of Corvus Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 72.25 M shares in the last 24 months. This purchase volume represents approximately $1.15 B in transactions.